Xiang-Ming Xu

RNA-mediated gene silencing of the RON receptor tyrosine kinase alters oncogenic phenotypes of human colorectal carcinoma cells

Xiang-Ming Xu, Da Wang, Qi Shen et al. · Oncogene · 2004 · 66 citations

Medicine, Molecular Biology, Oncology +14

RON and MET Co-overexpression Are Significant Pathological Characteristics of Poor Survival and Therapeutic Targets of Tyrosine Kinase Inhibitors in Triple-Negative Breast Cancer

Tian-Hao Weng, Minya Yao, Xiang-Ming Xu et al. · Cancer Research and Treatment · 2020 · 64 citations · Full text

Medicine, Oncology, Pharmacology +17

LINC00337 promotes tumor angiogenesis in colorectal cancer by recruiting DNMT1, which suppresses the expression of CNN1

Xiang-Ming Xu, Jiao Nie, Lin Lü et al. · Cancer Gene Therapy · 2020 · 41 citations

Medicine, Molecular Genetics, Oncology +14

Mechanisms of Cytoplasmic β-Catenin Accumulation and Its Involvement in Tumorigenic Activities Mediated by Oncogenic Splicing Variant of the Receptor Originated from Nantes Tyrosine Kinase

Xiang-Ming Xu, Yong-Qing Zhou, Minghai Wang · Journal of Biological Chemistry · 2005 · 30 citations · Full text

Medicine, Molecular Biology, Oncology +16

Semaphorin-7A contributes to growth, migration and invasion of oral tongue squamous cell carcinoma through TGF-β-mediated EMT signaling pathway.

Liu Tj, Guo Jl, Wang Hk et al. · PubMed · 2018 · 17 citations

Medicine, Cancer Biology, Oncology +16